Role of Diacylglycerol Kinases in Acute Myeloid Leukemia.
bone marrow
erythrocyte
granulocyte
inhibitors
lipid
megakaryocyte
monocyte
neutrophil
signaling
Journal
Biomedicines
ISSN: 2227-9059
Titre abrégé: Biomedicines
Pays: Switzerland
ID NLM: 101691304
Informations de publication
Date de publication:
01 Jul 2023
01 Jul 2023
Historique:
received:
18
04
2023
revised:
27
06
2023
accepted:
29
06
2023
medline:
29
7
2023
pubmed:
29
7
2023
entrez:
29
7
2023
Statut:
epublish
Résumé
Diacylglycerol kinases (DGKs) play dual roles in cell transformation and immunosurveillance. According to cancer expression databases, acute myeloid leukemia (AML) exhibits significant overexpression of multiple DGK isoforms, including
Identifiants
pubmed: 37509516
pii: biomedicines11071877
doi: 10.3390/biomedicines11071877
pmc: PMC10377028
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Italian Ministry of Education, University and Research
ID : 201799WCRH
Organisme : Department of Translational Medicine, Università del Piemonte Orientale
ID : FAR-2019
Références
Front Oncol. 2022 Jul 25;12:876981
pubmed: 35957912
Blood. 2022 Sep 22;140(12):1345-1377
pubmed: 35797463
Leukemia. 2022 Jul;36(7):1703-1719
pubmed: 35732831
Eur J Med Chem. 2019 Feb 15;164:378-390
pubmed: 30611057
Int J Mol Sci. 2019 Nov 13;20(22):
pubmed: 31766109
Nucleic Acids Res. 2019 Jul 2;47(W1):W556-W560
pubmed: 31114875
J Cell Biochem. 2019 Jun;120(6):10043-10056
pubmed: 30536880
Sci Transl Med. 2016 Jan 13;8(321):321ra7
pubmed: 26764158
J Hepatol. 2012 Jul;57(1):77-83
pubmed: 22425622
Neuro Oncol. 2018 Jan 22;20(2):151-152
pubmed: 29365204
J Biol Chem. 2014 Jan 17;289(3):1551-63
pubmed: 24302719
Int J Mol Sci. 2020 Jul 26;21(15):
pubmed: 32722576
J Cell Biochem. 2005 Mar 1;94(4):774-93
pubmed: 15578578
BMC Cancer. 2018 Apr 23;18(1):458
pubmed: 29688850
Blood. 2005 Sep 15;106(6):2175-82
pubmed: 15928040
J Enzyme Inhib Med Chem. 2020 Dec;35(1):96-108
pubmed: 31690133
Cancers (Basel). 2019 Dec 31;12(1):
pubmed: 31906064
Neuro Oncol. 2018 Jan 22;20(2):192-202
pubmed: 29048560
Oncogene. 2004 Jun 17;23(28):4828-38
pubmed: 15122338
Toxicol Rep. 2020 Feb 07;7:335-344
pubmed: 32090021
Blood. 2022 Sep 29;140(13):1533-1548
pubmed: 35895896
Biochem Biophys Res Commun. 2003 May 23;305(1):101-7
pubmed: 12732202
J Cell Physiol. 2017 Sep;232(9):2550-2557
pubmed: 27731506
Am J Hematol. 2021 May 1;96(5):580-588
pubmed: 33625756
Blood Res. 2020 Jul 31;55(S1):S1-S4
pubmed: 32719169
Oncogene. 2008 Feb 7;27(7):942-56
pubmed: 17700527
Cancer Discov. 2013 Jul;3(7):782-97
pubmed: 23558954
Nature. 2018 Oct;562(7728):526-531
pubmed: 30333627
Sci Signal. 2015 Apr 28;8(374):re6
pubmed: 25921290
Cancer Res. 2018 Aug 15;78(16):4692-4703
pubmed: 29967261
J Immunol. 1999 Jul 15;163(2):708-14
pubmed: 10395661
J Immunol. 2016 Aug 1;197(3):934-41
pubmed: 27342844
J Biol Chem. 1996 Apr 26;271(17):10334-40
pubmed: 8626603
Clin Cancer Res. 2018 Feb 1;24(3):608-618
pubmed: 29127121
Front Oncol. 2022 May 30;12:840046
pubmed: 35707351
Front Immunol. 2023 Apr 17;14:1043603
pubmed: 37138877
Pharmazie. 2019 Jul 1;74(7):418-422
pubmed: 31288898
Biochim Biophys Acta. 2007 Apr;1771(4):462-74
pubmed: 17276726
Nat Commun. 2019 Apr 3;10(1):1523
pubmed: 30944313
Exp Cell Res. 2018 Dec 15;373(1-2):211-220
pubmed: 30399372
Biochem Pharmacol. 2017 Jan 1;123:29-39
pubmed: 27974147
Biomedicines. 2021 Jan 06;9(1):
pubmed: 33419210
Clin Sci (Lond). 2020 Jul 17;134(13):1637-1658
pubmed: 32608491
Blood Cancer J. 2022 Aug 16;12(8):117
pubmed: 35973983
Int J Mol Sci. 2022 Mar 24;23(7):
pubmed: 35408889
J Lipid Res. 2016 Mar;57(3):368-79
pubmed: 26768655
N Engl J Med. 2014 Sep 11;371(11):1005-15
pubmed: 25207766